Efficacy Testing of Collagen and Zhuyin Drinks
- Conditions
- Skin Condition
- Interventions
- Dietary Supplement: Collagen Cubilose DrinkDietary Supplement: Placebo drink
- Registration Number
- NCT04266405
- Lead Sponsor
- TCI Co., Ltd.
- Brief Summary
To assess collagen and zhuyin drink on skin \& body condition improvement
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Healthy adults aged above 20 years old
- Subject who is not willing to participate in this study.
- Patients with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
- Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
- Vegetarian
- Subjects who have large spots (area >3 square centimeter) or abnormal acne.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Collagen and Zhuyin Drinks Collagen Cubilose Drink - Placebo drink Placebo drink -
- Primary Outcome Measures
Name Time Method The change of skin wrinkles Change from Baseline skin wrinkles at 4 weeks VISIA Complexion Analysis System was utilized to measure wrinkles. Units: arbitrary units
The change of skin moisture Change from Baseline skin moisture at 4 weeks Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120
The change of skin collagen density Change from Baseline skin collagen density at 4 weeks DermaLab® USB - 20 MHz High Freq. Ultrasound probe was utilized to scan and analyze skin collagen density. Units:Intensity score
The change of skin brightness Change from Baseline skin brightness at 4 weeks Glossymeter GL 200 was utilized to measure skin brightness. Units: arbitrary units
The change of interleukin-6 Change from Baseline skin brightness at 4 weeks Venous blood was sampled to measure concentrations of interleukin-6.
The change of Matrix metalloproteinase-1 Change from Baseline skin brightness at 4 weeks Venous blood was sampled to measure concentrations of Matrix metalloproteinase-1 .
The change of metallopeptidase inhibitor 1 Change from Baseline skin brightness at 4 weeks Venous blood was sampled to measure concentrations of metallopeptidase inhibitor 1.
The change of TEWL Change from Baseline TEWL at 4 weeks Tewameter® TM 300 was utilized to measure TEWL. Units: g/h/m2
The change of interleukin-8 Change from Baseline skin brightness at 4 weeks Venous blood was sampled to measure concentrations of interleukin-8.
The change of Tumor necrosis factor Change from Baseline skin brightness at 4 weeks Venous blood was sampled to measure concentrations of Tumor necrosis factor.
- Secondary Outcome Measures
Name Time Method The change of skin pores Change from Baseline skin pores at 4 weeks VISIA Complexion Analysis System was utilized to measure skin pores. Units: arbitrary units
The change of skin texture Change from Baseline skin texture at 4 weeks VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
The change of skin spots Change from Baseline skin spots at 4 weeks VISIA Complexion Analysis System was utilized to measure skin spots. Units: arbitrary units
The change of red areas Change from Baseline red areas at 4 weeks VISIA Complexion Analysis System was utilized to measure red areas. Units: arbitrary units
Trial Locations
- Locations (1)
Chia Nan University of Pharmacy & Science
🇨🇳Tainan, Taiwan